Clinical Study Results
Study Sponsor: AstraZeneca
Treatment Studied: Benralizumab
Study Purpose: This study was done to learn how 3 new
health apps worked for participants with
severe asthma taking benralizumab
Protocol Number: D3250R00061
Thank you!
Thank you for taking part in the clinical study for the study drug benralizumab.
AstraZeneca sponsored this study and believes it is important to share the results.
An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1